Found 6274 matching trials
Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia PHASE2 Waldenström's Macroglobulinemia (lymphoplasmacytic lymphoma, WM) remains in...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients PHASE2 The goal of this clinical research study is to learn if temozolomide alone ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants PHASE1 ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Show More Location
Frontage Clinical Services
Learn More & Join Trial
Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age PHASE3 This double-blind 8 week study will evaluate dose response, efficacy (blood...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 PHASE3 Summary
In patients with prostate cancer (PC) who have only biochemically ...
Show More Location
Copenhagen University hospital, Rigshospitalet
Learn More & Join Trial
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy PHASE3 Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Show More Location
Warner Chilcott Investigational Site
Learn More & Join Trial
A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis PHASE2 The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Show More Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Learn More & Join Trial
Treatment of Erectile Dysfunction I PHASE3 Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Show More Location
Warner Chilcott Investigational Site
Learn More & Join Trial
Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD) PHASE2 This is a multi-center, randomized, double blind, placebo-controlled phase ...
Show More Location
Beijing Chao-Yang Hospital, Capital Medical University
Learn More & Join Trial
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) PHASE3 Comparison of the safety and effectiveness of standard drug dosing versus a...
Show More Location
Multiple Locations
Learn More & Join Trial